Tenaya Therapeutics, Inc. (TNYA) Misses Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts TNYA Hot Sheet
Join SI Premium – FREE
Tenaya Therapeutics, Inc. (NASDAQ: TNYA) reported Q2 EPS of ($0.20), $0.14 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.11 million versus the consensus estimate of $2.5 million.
For earnings history and earnings-related data on Tenaya Therapeutics, Inc. (TNYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- JPMorgan Upgrades FOX Corp. (FOXA) to Overweight
- Syensqo SA (SYENS:BB) PT Raised to EUR100 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
